Investor Overview

Corporate Profile
 

Stereotaxis is the global leader in innovative robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. Its mission is the discovery, development and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide unsurpassed patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. Over 100 issued patents support the Stereotaxis platform. Stereotaxis' core Epoch™ Solution includes the Niobe® ES remote magnetic navigation system, the Odyssey® portfolio of lab optimization, networking and patient information management systems, and the Vdrive™ robotic navigation system and consumables, which have received regulatory clearance in the United States, European Union, Japan, Canada, China, and elsewhere.

FINANCIAL NEWS
09/16/19
ST. LOUIS, Mo. , Sept. 16, 2019 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE American: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that Kimberly Peery has been appointed Stereotaxis Chief Financial Officer, effective October 1, 2019
09/03/19
ST. LOUIS , Sept. 03, 2019 (GLOBE NEWSWIRE) -- Stereotaxis (OTCQX: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that its common stock has been approved for listing on the NYSE American.
08/08/19
ST. LOUIS , Aug. 08, 2019 (GLOBE NEWSWIRE) -- Stereotaxis (OTCQX: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today reported financial results for the second quarter ended June 30, 2019 . In a separate press release issued concurrently with

Copyright West LLC. Minimum 15 minutes delayed.

RECENT FILINGS

Filing date Form
EFFECT
424B3
3
S-3
Receive E-mail Alerts
 
Alerts are e-mailed to you whenever certain new company information is posted to this site.
Investor Contacts
 
Kimberly Peery
Chief Financial Officer
Stereotaxis, Inc.
investors@stereotaxis.com
(314) 678-6100
© Copyright Stereotaxis 2019